PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals as a very limited distribution partner for the novel drug GIVLAARI™ (givosiran). GIVLAARI is the first and only FDA-approved medicine indicated for the treatment of adults with Acute Hepatic Porphyria (AHP). GIVLAARI becomes the second RNAi therapeutic from Alnylam approved by the FDA in the last 16 months and the first-ever approved GalNAc-Conjugate RNA therapeutic, a landmark in the advancement of ...
READ MORE
|
In the year ahead, health care promises to be a central issue in the 2020 election. According to a report issued this week at the 2o19 American Society of Health System Pharmacists Midyear Clinical Meeting & Exposition from McKesson RxO, which detailed the major trends and challenges in health care ahead, the increasing complexity of integrated delivery networks and a need for more technology and associated analytics were highlighted as major areas of focus in the year ahead and in fut...
READ MORE
|
Grocery store Kroger and drug store Walgreens are teaming up. In an effort to cut supplier costs, the two companies want to start buying merchandise together, CNBC reported. The chain retailers will call this partnership the Retail Procurement Alliance, and will have them identifying overlap in products that they both are receiving so they can place their orders together. This will increase scale and lower costs for both parties, as well as reduce waste. The alliance will also evaluate if it'...
READ MORE
|
The Labour Party’s election manifesto presents something of a mixed bag for pharmaceutical companies. In broad terms, the party’s pledge to increase total R&D expenditure to 3% of GDP by 2030 (compared to 1.69% in 2017) should mean more funding is available for cutting-edge research. Labour wants the NHS to be at the forefront of developments in the fields of genomics and cell therapies, suggesting some of this funding may be targeted at those specialisms. The Party has also expr...
READ MORE
|
In a survey conducted by the Royal Pharmaceutical Society and Pharmacist Support, 80% of respondents said they were at a ‘high’ or ‘very high’ risk of burnout through exhaustion. Almost half of pharmacists who responded to a survey on workforce wellbeing said they worry about making mistakes or providing a poor-quality service to their patients. Four out of five respondents (80%) said they were at ‘high’ or ‘very high’ risk of burnout through exhau...
READ MORE
|
A survey has shown that the pharmaceutical industry believes R&D will see a lot of benefit from digital transformation and that AI will be at the forefront of this. New research has shown that the global pharmaceutical industry spends a significant amount of revenue on research and development (R&D) activities that are failing to deliver projected returns but that digital transformation with artificial intelligence (AI) is seen as a major step forward towards enhancing R&D productivi...
READ MORE
|
As debate over drug pricing proposals rolls on in Washington, White House advisers have concluded House Speaker Nancy Pelosi's aggressive pricing plan would result in 100 fewer new drugs over a decade, lowering Americans' expected lifespan along the way. Unveiled this fall, Pelosi's plan calls for Medicare price negotiations, an international pricing index, potential fines for drugmakers who won't negotiate and more. President Donald Trump originally tweeted that it was “gr...
READ MORE
|
Aberdeen announced Aberdeen Intent for Salesforce – the first Salesforce-native solution that identifies and pushes intent-qualified opportunities directly into your Salesforce instance so your sales team never misses another deal. Aberdeen Intent for Salesforce uses machine learning to track the online research of millions of companies across the internet to generate the most accurate intent score available with client measured accuracy as high as 91%.Aberdeen Intent for Salesforce is bas...
READ MORE
|
Aberdeen, a research firm and intent-based sales and marketing solutions provider, supported by Kapost, recently released new research showing best-in-class B2B firms significantly benefit by executing on consistent, intentional content strategies supporting end-to-end customer experience (CX). Best-in-Class firms see 48% greater customer lifetime value (LTV) and nearly 300% greater year-over-year improvement in customer effort scores. "The considered purchase process today is long and invo...
READ MORE
|
Aberdeen announced Aberdeen Behavioral Technographics – the industry’s first install (technographic) data that actively measures technology in use. Legacy technographic data only provides a single yes/no estimate as to whether a company uses a specific technology. Aberdeen Behavioral Technographics is the first to measure technology usage down to company location, number of users and pains and priorities of the usage. In numerous tests, Aberdeen Behavioral Technographics has proven t...
READ MORE
|